Study guide

2.4 Psychosocial, Nutritional, Cognitive & Mental Health Screening Instruments

ANCC Adult-Gerontology Primary Care Nurse Practitioner AGPCNP-BC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The AGPCNP-BC Examination: Blueprint, Format & Scoring

1.1 The AGPCNP-BC Blueprint, Exam Format, Scoring, Eligibility & Renewal

2 Chapter 2: Assessment Foundations & Lifespan Considerations

2.1 Comprehensive Health History, Symptom Analysis & Lifespan Variations 2.2 Physical Examination Techniques & Age-Related Physiological Changes 2.3 Functional Assessment (Katz ADL / Lawton IADL) & Frailty Syndromes 2.4 Psychosocial, Nutritional, Cognitive & Mental Health Screening Instruments 2.5 Health Screening Guidelines (USPSTF) & Adult Immunization Schedules (CDC/ACIP)

3 Chapter 3: Diagnostic Reasoning & Clinical Interpretation

3.1 Diagnostic Reasoning, Clinical Decision-Making & Differential Diagnosis Formulation 3.2 Routine & Specialized Laboratory Interpretation 3.3 Diagnostic Imaging, ECG Interpretation & Pulmonary Function Testing 3.4 Evidence-Based Testing, Pre-Test Probability & Choosing Wisely Principles

4 Chapter 4: Cardiovascular Disorders

4.1 Hypertension: 2025 AHA/ACC Guideline, Resistant HTN & Secondary HTN 4.2 Dyslipidemia & ASCVD Risk Calculation, Statin Therapy & Non-Statin Agents 4.3 Coronary Artery Disease, Stable Angina & Post-ACS Outpatient Management 4.4 Heart Failure (HFrEF/HFpEF), Atrial Fibrillation & Peripheral Vascular Disease

5 Chapter 5: Respiratory Disorders

5.1 Asthma: GINA 2026 Guidelines, Phenotypes, Stepwise Pharmacotherapy & Action Plans 5.2 COPD: GOLD 2026 Report, ABE Staging, Triple Inhalers & Exacerbations 5.3 Lower Respiratory Infections (CAP, Bronchitis), Pleural Disease & Solitary Pulmonary Nodules

6 Chapter 6: HEENT & Allergic/Immunologic Disorders

6.1 Eye & Vision Disorders in Adult-Gerontology Primary Care 6.2 Ear, Hearing & Vestibular Disorders 6.3 Nose, Sinus, Oropharyngeal & Oral Cavity Disorders 6.4 Allergic & Immunologic Disorders: Anaphylaxis, Urticaria, Angioedema & Immunodeficiency

7 Chapter 7: Endocrine & Metabolic Disorders

7.1 Type 2 Diabetes Mellitus: ADA Standards of Care, Pharmacotherapy & Microvascular Complications 7.2 Thyroid Disorders: Hypothyroidism, Hyperthyroidism, Thyroiditis & Nodules 7.3 Adrenal & Pituitary Disorders: Adrenal Insufficiency, Cushing's, Hyperaldosteronism & Hypopituitarism 7.4 Metabolic Bone Disease: Osteopenia, Osteoporosis (FRAX, DEXA) & Hyperparathyroidism

8 Chapter 8: Gastrointestinal & Hepatic Disorders

8.1 Upper GI Disorders: GERD, Barrett's Esophagus, PUD, H. pylori & Gastritis 8.2 Lower GI Disorders: Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD) & Diverticular Disease 8.3 Hepatobiliary Disorders: MASLD/MASH, Viral & Alcoholic Hepatitis, Cirrhosis & Cholelithiasis 8.4 Acute & Chronic Abdominal Pain Syndromes, GI Bleeding & Colorectal Cancer Screening

9 Chapter 9: Renal, Urological & Men's Health

9.1 Chronic Kidney Disease: KDIGO Staging, Albuminuria Management & Renoprotective Strategies 9.2 Urinary Tract Infections (Uncomplicated, Complicated, Recurrent), Pyelonephritis & Microscopic Hematuria 9.3 Men's Health: Benign Prostatic Hyperplasia, Prostatitis, Epididymitis & Erectile Dysfunction

10 Chapter 10: Musculoskeletal & Rheumatologic Disorders

10.1 Degenerative & Overuse Musculoskeletal Disorders: Osteoarthritis, Tendinopathies & Spine Disorders 10.2 Autoimmune Rheumatologic Disorders: Rheumatoid Arthritis, SLE, Polymyalgia Rheumatica & Giant Cell Arteritis 10.3 Crystal Arthropathies & Fibromyalgia: Gout, Pseudogout & Centralized Pain Syndromes

11 Chapter 11: Neurological & Psychiatric Disorders

11.1 Headaches (Migraine, Tension, Cluster) & Cranial Neuralgias 11.2 Cerebrovascular Disease, TIA, Peripheral Neuropathies & Movement Disorders (Parkinson's) 11.3 Mood & Anxiety Disorders: Major Depressive Disorder, Generalized Anxiety Disorder & PTSD 11.4 Substance Use Disorders: Alcohol, Tobacco, Opioids & Cannabis in Primary Care

12 Chapter 12: Dermatologic, Hematologic & Infectious Disease

12.1 Primary Dermatologic Lesions, Inflammatory Dermatoses & Cutaneous Malignancies 12.2 Common Infectious Diseases: Skin/Soft Tissue Infections, Tick-Borne Illnesses & Viral Syndromes 12.3 Sexually Transmitted Infections (STIs): CDC Guidelines, Screening & Partner Management 12.4 Hematologic Disorders: Anemias (Microcytic, Normocytic, Macrocytic), Leukopenia & Coagulopathies

13 Chapter 13: Geriatric Syndromes, Pharmacology & Palliative Care

13.1 The Geriatric 5Ms Framework, Multimorbidity & Polypharmacy Deprescribing 13.2 Beers Criteria 2023 Update & STOPP/START Prescribing Rules 13.3 Pharmacokinetics, Pharmacodynamics & Pharmacogenomics Across the Adult Lifespan 13.4 Dementia vs. Delirium vs. Depression: Differential Diagnostics & Management 13.5 Falls, Mobility Impairment, Pressure Injury Prevention & Palliative Care Transitions

14 Chapter 14: Gynecologic & Women's Health

14.1 Contraceptive Management, Emergency Contraception & Preconception Counseling 14.2 Perimenopause, Menopause & Hormone Replacement Therapy (HRT) 14.3 Gynecologic Infections (Vaginitis, PID), Abnormal Uterine Bleeding & Cervical Cancer Screening (USPSTF/ASCCP)

15 Chapter 15: Plan-of-Care Process: Behavior Change, Education & Care Coordination

15.1 Behavioral Change: Motivational Interviewing, Models & Theories 15.2 Patient Education, Shared Decision-Making, Referrals, Care Coordination & Plan Reassessment

16 Chapter 16: APRN Professional Practice, Ethics, Policy & Quality Improvement

16.1 APRN Scope of Practice, Consensus Model, Collaborative Practice & Credentialing 16.2 Bioethics, Informed Consent, Advance Directives & Surrogate Decision-Making 16.3 Environmental & Social Determinants of Health, Health Equity & Culturally Responsive Care 16.4 Evidence-Based Practice (EBP), Quality Improvement (QI) Methodologies & Healthcare Economics

2.4 Psychosocial, Nutritional, Cognitive & Mental Health Screening Instruments

Key Takeaways Explain This Topic AI

The Mini-Cog takes about 3 minutes and combines 3-item recall with a clock drawing; a total score of 0 to 2 out of 5 is a positive screen requiring full cognitive evaluation.

The MoCA is scored out of 30 with 26 or above considered normal, adds one point for 12 or fewer years of education, and is more sensitive than the MMSE for mild cognitive impairment.

The PHQ-2 is the two-item depression pre-screen; a score of 3 or more triggers the full PHQ-9, where 5, 10, 15 and 20 mark mild, moderate, moderately severe and severe depression.

The Geriatric Depression Scale short form has 15 yes/no items with no somatic questions, and a score above 5 is a positive screen in older adults whose physical symptoms would confound the PHQ-9.

AUDIT-C is positive at 4 or more for men and 3 or more for women, and the Mini Nutritional Assessment Short Form flags malnutrition risk at 11 or less out of 14.

Last updated: August 2026

Psychosocial, Nutritional, Cognitive & Mental Health Screening Instruments

The ANCC test content outline lists two separate skill statements under Patient Assessment Process that are easy to skim past: psychosocial assessment (health literacy, lifestyle, nutritional, caregiver/support, cultural, spiritual) and cognitive and mental health assessment using screening tools . Board items in this space are rarely "what is depression"; they are "which instrument, what cut score, and what do you do with a positive result."

A screening instrument is not a diagnosis. Every tool below identifies people who need further evaluation. Confusing a positive screen with a diagnosis is one of the most reliably tested errors on the examination.

1. Cognitive Screening Instruments +---------------------------------------------------------------------------------------------------+

  • | COGNITIVE SCREENING INSTRUMENT COMPARISON |
  • | |
  • | INSTRUMENT TIME MAX POSITIVE SCREEN BEST USE / CAVEAT |
  • | ========== ==== === =============== ==================== |
  • | Mini-Cog ~3 min 5 0 to 2 Fastest validated screen. 3-item recall |
  • | (0-3) + clock draw (0 or 2). Minimal |
  • | education and language bias. |
  • | --------------------------------------------------------------------------------------------- |
  • | MoCA ~10 min 30 < 26 Most sensitive for MILD cognitive |
  • | impairment. +1 point if <= 12 years of |
  • | education. Requires certification to use. |
  • | --------------------------------------------------------------------------------------------- |
  • | MMSE ~7 min 30 < 24 Long-standing, but insensitive to mild |
  • | impairment and to executive dysfunction; |
  • | heavily education- and language-biased. |
  • | --------------------------------------------------------------------------------------------- |
  • | SLUMS ~7 min 30 Educated: < 27 Detects mild neurocognitive disorder; |
  • | Non-HS grad: < 25 free, developed by the VA. |
  • | --------------------------------------------------------------------------------------------- |
  • | AD8 ~3 min 8 >= 2 INFORMANT questionnaire. The tool of choice |
  • | when the patient minimizes or the history |
  • | comes from a caregiver. |
  • +---------------------------------------------------------------------------------------------------+

Interpreting the clock draw. In the Mini-Cog, the patient draws a clock face with all numbers and sets the hands to a stated time. A normal clock scores 2 ; any abnormality scores 0 - there is no partial credit. The clock draw taps executive function, visuospatial construction and working memory simultaneously, which is why it survives as the shortest useful screen.

Which one to choose. For a Medicare Annual Wellness Visit, which requires detection of cognitive impairment, the Mini-Cog or AD8 is efficient. When a patient or family reports subtle word-finding difficulty, medication errors or getting lost while driving but the Mini-Cog is normal, escalate to the MoCA , which detects mild cognitive impairment the MMSE misses. When the patient is a poor historian or lacks insight, an informant tool such as the AD8 outperforms any patient-administered screen.

  • Warning
  • Never screen cognition during delirium. A screening score obtained while a patient is acutely
  • ill, hypoxic, in pain, febrile, or freshly dosed with an anticholinergic or an opioid measures the

acute illness, not the baseline. Treat the acute problem, then rescreen.

2. Mood, Anxiety, Trauma and Suicide Risk

Instrument Items Positive screen Notes

PHQ-2 2 >= 3 (range 0-6) Depressed mood and anhedonia over 2 weeks. Pre-screen only; a positive result requires the PHQ-9.

PHQ-9 9 5 mild / 10 moderate / 15 moderately severe / 20 severe Maps directly to DSM-5 criteria; also a treatment-response measure. Item 9 screens suicidal ideation and must be reviewed on every administration.

GDS-15 15 > 5 Yes/no format, no somatic items , so it is preferred in older adults with comorbid illness where fatigue, poor sleep and appetite change would inflate a PHQ-9.

GAD-7 7 5 mild / 10 moderate / 15 severe; >= 10 warrants evaluation Generalized anxiety; also reasonable for panic, social anxiety and PTSD case-finding.

PC-PTSD-5 5 >= 3 Primary care PTSD screen; positive result should prompt a diagnostic interview or the PCL-5.

C-SSRS Varies Any "yes" to items 3, 4 or 5 Columbia Suicide Severity Rating Scale; the standard structured suicide-risk screen.

USPSTF context. The Task Force recommends screening all adults for depression (Grade B) and adults aged 64 and younger for anxiety disorders (Grade B), each with adequate systems in place for accurate diagnosis, effective treatment and appropriate follow-up. The Task Force concluded that current evidence is insufficient to assess screening for suicide risk in asymptomatic adults - which is not permission to ignore risk in a patient with a positive depression screen.

3. Substance Use Screening

AUDIT-C (3 items, 0-12): positive at >= 4 in men and >= 3 in women . The single-item screener - "How many times in the past year have you had 5 or more drinks in a day (4 or more for women)?" - is positive at >= 1 .

CAGE (4 items): >= 2 is a positive screen. It detects lifetime dependence rather than current hazardous drinking and misses binge patterns, so it has largely been supplanted by AUDIT-C.

TAPS and the NIDA Quick Screen cover tobacco, alcohol, prescription medication and other substance use in one instrument.

DAST-10 : >= 3 suggests a drug problem warranting further assessment.

Any positive substance screen should be followed by SBIRT : Screening, B rief I ntervention, and R eferral to T reatment.

4. Nutritional Screening

Older adults, and particularly the frail elderly age band on the ANCC blueprint, are at high risk of protein-calorie malnutrition that is invisible on a routine visit.

Instrument Scoring Action

Mini Nutritional Assessment - Short Form (MNA-SF) 0-14 12-14 normal; 8-11 at risk; 0-7 malnourished. A score of <= 11 triggers full assessment.

Malnutrition Universal Screening Tool (MUST) 0-6 0 low risk; 1 medium; >= 2 high risk - dietitian referral.

Unintentional weight loss Clinical > 5% in 6 months or > 10% in 12 months is significant regardless of any instrument.

Remember the reversible contributors before labeling weight loss idiopathic: ill-fitting dentures and oral pain, dysgeusia from medications, dysphagia, depression, food insecurity, alcohol, and the " Meals on Wheels " mnemonic of medication effects, emotional problems, anorexia tardive, paranoia, swallowing disorders, oral factors, no money, wandering, hyperthyroidism, enteric problems, eating problems, low-salt/low-cholesterol diets, and social/shopping problems.

5. Health Literacy, Caregiver Strain, Spirituality and Social Risk

Health literacy. Roughly one in three US adults has basic or below-basic health literacy. Rather than trying to identify who is affected, apply universal precautions : plain language, no more than three key points per visit, and teach-back on every new medication or self-management task. Validated brief instruments include the Newest Vital Sign (6 questions about an ice-cream nutrition label; <= 3 suggests limited literacy), the REALM-SF (7 words to pronounce) and the Single Item Literacy Screener ("How often do you need to have someone help you when you read instructions or pamphlets from your doctor?").

Caregiver strain. The Zarit Burden Interview (short forms of 4, 12 or 22 items) and the Modified Caregiver Strain Index (13 items; >= 7 indicates high strain) quantify the burden carried by the family member sitting in your exam room. Screening the caregiver is a legitimate part of the patient's plan of care, because caregiver collapse is one of the most common precipitants of nursing-home placement.

Spiritual assessment. The FICA tool structures the conversation: F aith or belief, I mportance and influence, C ommunity, and A ddress in care. HOPE is an alternative. These are not conversion opportunities; they identify sources of meaning, coping and decision-making that will matter enormously in advance care planning.

Social risk. The PRAPARE tool and the CMS Accountable Health Communities Health-Related Social Needs screening tool cover housing instability, food insecurity, transportation, utility needs and interpersonal safety. The two-item Hunger Vital Sign is a rapid food-insecurity screen. Positive findings should be documented with ICD-10-CM Z codes (Z55-Z65) and linked to a concrete referral.

Elder mistreatment. The Elder Abuse Suspicion Index (EASI) is a 6-item tool for cognitively intact older adults; a "yes" to any of questions 2 through 6 is a positive screen. Interview the patient alone , away from the accompanying person, and know your state's mandatory reporting statute.